1. Home
  2. AMZE vs ITOC Comparison

AMZE vs ITOC Comparison

Compare AMZE & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amaze Holdings Inc.

AMZE

Amaze Holdings Inc.

HOLD

Current Price

$0.33

Market Cap

14.3M

ML Signal

HOLD

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.36

Market Cap

7.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AMZE
ITOC
Founded
2019
1998
Country
United States
China
Employees
4
N/A
Industry
Beverages (Production/Distribution)
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
7.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMZE
ITOC
Price
$0.33
$0.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
991.8K
30.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6,741.66
N/A
Revenue Next Year
$100.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.31
52 Week High
$11.76
$0.65

Technical Indicators

Market Signals
Indicator
AMZE
ITOC
Relative Strength Index (RSI) 43.82 31.40
Support Level $0.30 $0.32
Resistance Level $0.41 $0.49
Average True Range (ATR) 0.04 0.03
MACD -0.00 0.00
Stochastic Oscillator 34.59 26.69

Price Performance

Historical Comparison
AMZE
ITOC

About AMZE Amaze Holdings Inc.

Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.

Share on Social Networks: